Grand Pharmaceutical Group Limited (FRA:MX6A)

Germany flag Germany · Delayed Price · Currency is EUR
0.6850
+0.0050 (0.74%)
Last updated: Apr 24, 2026, 9:55 AM CET
Market Cap2.47B -3.5%
Revenue (ttm)1.34B +5.5%
Net Income135.78M -49.7%
EPS0.04 -49.7%
Shares Outn/a
PE Ratio18.18
Forward PE13.44
Dividend0.03 (4.32%)
Ex-Dividend DateApr 14, 2025
Volumen/a
Average Volume522
Open0.6850
Previous Close0.6800
Day's Range0.6850 - 0.6850
52-Week Range0.6400 - 1.0700
Betan/a
RSI38.56
Earnings DateMay 19, 2026

About FRA:MX6A

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additive... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 12,614
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol MX6A

Financial Performance

In 2025, FRA:MX6A's revenue was 12.28 billion, an increase of 5.48% compared to the previous year's 11.64 billion. Earnings were 1.24 billion, a decrease of -49.73%.

Financial numbers in HKD Financial Statements